期刊文献+

急性冠脉综合征病人脑卒中发生率及其预后

The incidence and prognosis of stroke in patients with acute coronary syndrome
暂未订购
导出
摘要 目的探讨急性冠脉综合症(ACS)病人合并卒中的危险因素及其预后。方法共2623例ACS住院病人入选,观察基本临床资料和相关事件。结果住院期间51例(1.94%)发生卒中,其中16例(31.37%)死亡,ST段抬高的心肌梗塞组的卒中发病率(3.11%)明显高于不稳定性心绞痛组(1.61%),P<0.05,院内卒中的发生与其它血管事件密切相关,包括心力衰竭、心源性休克、心跳骤停、心房纤颤、急性肾功能衰竭和糖尿病。结论ACS住院病人发生卒中率虽不高但其病死率高达31.37%,对此高危人群应采取个体化治疗措施。 Objective To investigate (ACS) associated with stroke. Methods the risk factors and prognosis of patients with acute coronary syndrome 2623 hospitalized patients with ACS were enrolled for the retrospective analysis. The baseline clinical records and related- events to stroke were studied. Results During in- hospital time, 51 patients (1.9%) were found with stroke and 16 (31.37%) of the 51 patients died. The incidence of stroke (3.11% ) in ST- elevation myocardial infarction was significantly higher than that ( 1.61% ) in unstable angina, P 〈 0.05. The incidence of in- hospital stroke'was closely related to other vascular events, including heart failure, cardiac arrest, auricular fibrillation, acute renal failure and diabetes mellitus. Conclusion stroke in hospitalized patients with ACS is low, the mortality is high, the individualized regimen should be used for treatment of this high risk patients.
出处 《右江民族医学院学报》 2005年第6期800-802,共3页 Journal of Youjiang Medical University for Nationalities
关键词 冠状动脉疾病 脑血管意外 危险因素 预后 coronary disease cerebrovascular accident risk factors
  • 相关文献

参考文献2

二级参考文献14

  • 1谭慧琼,朱俊,梁岩,章晏,刘力生,代表OASIS登记试验中国地区协作组.非ST段抬高的急性冠状动脉综合征二年随访[J].中华医学杂志,2005,85(3):184-188. 被引量:12
  • 2Piegas LS, Flather M, Pogue J,et al. The Organization to Assess Strategies for Ischemic Syndromes (OASIS) registry in patients with unstable angina. Am J Cardiol,1999,84: 7M-12M.
  • 3Newby LK, Bhapkar MV, White HD,et al. Predictors of 90-day outcome in patients stabilized after acute coronary syndromes. Eur Heart J, 2003,24:172-181.
  • 4Theroux P, Fuster V. Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction. Circulation,1998,97: 1195-1206.
  • 5Cohen M, Demers C, Gurfinkel EP,et al. A comparison of low molecular weight heparin with unfractionated heparin for unstable coronary artery disease: Efficacy and Safety of Subcutaneous Enoxparin in Non-Q-wave Coronary Events Study Group. N Engl J Med,1997,337: 447-452.
  • 6Spencer FA, Santopinto JJ, Gore JM, et al. Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol,2002,90:1056-1061.
  • 7Chang WC, Harrington RA, Simoons ML, et al. Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction? Insights from the PURSUIT Trial. Eur Heart J,2002 ,23:1102-1111.
  • 8Gurfinkel EP, J Manos EJ, Mejail RI, et al. Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia. J Am Coll Cardiol,1995,26: 313-318.
  • 9The SYNERGY Executive Committee. Superior Yield of the New strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa inhibitors. The SYNERGY trial: study design and rationale. Am Heart J,2002,143:952-960.
  • 10The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med,2000,342: 145-153.

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部